Abstract
The Vav family is a group of signal transduction molecules with oncogenic potential that play important roles in development and cell signaling. Members of this family are distributed in all animal metazoans but not in unicellular organisms. Recent genomic studies suggest that the function of Vav proteins co-evolved with tyrosine kinase pathways, probably to assure the optimal conversion of extracellular signals into biological responses coupled to the cytoskeleton and gene transcription. To date, the best-known function of Vav proteins is their role as GDP/GTP exchange factors for Rho/Rac molecules, a function strictly controlled by tyrosine phosphorylation. Recent publications indicate that this function is highly dependent on the interaction of adaptor proteins that aid in the proper phosphorylation of Vav proteins, their interaction with other signaling molecules, and in modulating the strength of their signal outputs. In addition to the function of Vav proteins as exchange factors, there is increasing evidence suggesting that Vav proteins can mediate other cellular functions independently of their exchange activities, probably by working themselves as adaptor molecules. In this review, we will give a summary of the recent advances in this field, placing special emphasis on the non-catalytic roles of Vav and its interaction with other adaptor molecules.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aghazadeh B, Lowry WE, Huang XY, Rosen MK . 2000 Cell 102: 625–633
Arudchandran R, Brown MJ, Peirce MJ, Song JS, Zhang J, Siraganian RP, Blank U, Rivera J . 2000 J. Exp. Med. 191: 47–60
Billadeau DD, Mackie SM, Schoon RA, Leibson PJ . 2000 J. Immunol. 164: 3971–3981
Briggs SD, Sharkey M, Stevenson M, Smithgall TE . 1997 J. Biol. Chem. 272: 17899–17902
Bubeck Wardenburg J, Pappu R, Bu JY, Mayer B, Chernoff J, Straus D, Chan AC . 1998 Immunity 9: 607–616
Bustelo XR . 2000 Mol. Cell. Biol. 20: 1461–1477
Costello PS, Walters AE, Mee PJ, Turner M, Reynolds LF, Prisco A, Sarner N, Zamoyska R, Tybulewicz VL . 1999 Proc. Natl. Acad. Sci. USA 96: 3035–3040
Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR . 1997 Nature 385: 169–172
Doody GM, Billadeau DD, Clayton E, Hutchings A, Berland R, McAdam S, Leibson PJ, Turner M . 2000 EMBO J. 19: 6173–6184
Doody GM, Bell SE, Vigorito E, Clayton E, McAdam S, Toozie R, Fernandez C, Lee IJ, Turner M . 2001 Nat. Immunol. 6: 482–484
Dower NA, Stang SL, Bottorff DA, Ebinu JO, Dickie P, Ostergaard HL, Stone JC . 2000 Nat. Immunol. 1: 317–321
Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC . 1998 Science 280: 1082–1086
Fackler OT, Lu X, Frost JA, Geyer M, Jiang B, Luo W, Abo A, Alberts AS, Peterlin BM . 2000 Mol. Cell. Biol. 20: 2619–2627
Fackler OT, Luo W, Geyer M, Alberts AS, Peterlin BM . 1999 Mol. Cell. 3: 729–739
Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, Schlessinger J . 1998 EMBO J. 17: 414–422
Fang N, Koretzky GA . 1999 J. Biol. Chem. 274: 16206–16212
Finco TS, Kadlecek T, Zhang W, Samelson LE, Weiss A . 1998 Immunity 9: 617–626
Fischer KD, Kong YY, Nishina H, Tedford K, Marengere LE, Kozieradzki I, Sasaki T, Starr M, Chan G, Gardener S, Nghiem MP, Bouchard D, Barbacid M, Bernstein A, Penninger JM . 1998 Curr. Biol. 8: 554–562
Fischer KD, Zmuldzinas A, Gardner S, Barbacid M, Bernstein A, Guidos C . 1995 Nature 374: 474–477
Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF . 1999 J. Immunol. 162: 7088–7094
Han J, Das B, Wei W, Van Aelst L, Mosteller RD, Khosravi-Far R, Westwick JK, Der CJ, Broek D . 1997 Mol. Cell. Biol. 17: 1346–1353
Herna Remkema G, Saksela K . 2000 Front Biosci. 5: D268–D283
Holsinger LJ, Graef IA, Swat W, Chi T, Bautista DM, Davidson L, Lewis RS, Alt FW, Crabtree GR . 1998 Curr. Biol. 8: 563–572
Katzav S, Martin-Zanca D, Barbacid M . 1989 EMBO J. 8: 2283–2290
Kim HH, Tharayil M, Rudd CE . 1998 J. Biol. Chem. 273: 296–301
Ku GM, Yablonski D, Manser E, Lim L, Weiss A . 2001 EMBO J. 20: 457–465
Kuhne MR, Ku G, Weiss A . 2000 J. Biol. Chem. 275: 2185–2190
Li X, Sandoval D, Freeberg L, Carter RH . 1997 J. Immunol. 158: 5649–5657
Lopez-Lago M, Lee H, Cruz C, Movilla N, Bustelo XR . 2000 Mol. Cell. Biol. 20: 1678–1691
Lorenzo PS, Beheshti M, Pettit GR, Stone JC, Blumberg PM . 2000 Mol. Pharmacol. 57: 840–846
Manninen A, Herma Renkema G, Saksela K . 2000 J. Biol. Chem. 275: 16513–16517
Movilla N, Bustelo XR . 1999 Mol. Cell. Biol. 19: 7870–7885
Musci MA, Motto DG, Ross SE, Fang N, Koretzky GA . 1997 J. Immunol. 159: 1639–1647
O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL, Fearon DT . 1998 Immunity 8: 635–645
Okumura K, Kaneko Y, Nonoguchi K, Nishiyama H, Yokoi H, Higuchi T, Itoh K, Yoshida O, Miki T, Fujita J . 1997 Oncogene 14: 713–720
Onodera H, Motto DG, Koretzky GA, Rothstein DM . 1996 J. Biol. Chem. 271: 22225–22230
Raab M, da Silva AJ, Findell PR, Rudd CE . 1997 Immunity 6: 155–164
Ren XD, Schwartz MA . 1998 Curr. Opin. Genet. Dev. 8: 63–67
Roshal M, Zhu Y, Planelles V . 2001 Apoptosis 6: 103–116
Schuebel KE, Movilla N, Rosa JL, Bustelo XR . 1998 EMBO J. 17: 6608–6621
Serfling E, Berberich-Siebelt F, Chuvpilo S, Jankevics E, Klein-Hessling S, Twardzik T, Avots A . 2000 Biochim. Biophys. Acta 1498: 1–18
Skowronski J, Greenberg ME, Lock M, Mariani R, Salghetti S, Swigut T, Iafrate AJ . 1999 Cold Spring Harb. Symp. Quant. Biol. 64: 453–463
Swigut T, Shohdy N, Skowronski J . 2001 EMBO J. 20: 1593–1604
Trenkle T, McClelland M, Adlkofer K, Welsh J . 2000 Gene 245: 139–149
Tuosto L, Michel F, Acuto O . 1996 J. Exp. Med. 184: 1161–1166
Turner M, Mee PJ, Walters AE, Quinn ME, Mellor AL, Zamoyska R, Tybulewicz VL . 1997 Immunity 7: 451–460
Weng WK, Jarvis L, LeBien TW . 1994 J. Biol. Chem. 269: 32514–32521
Wu J, Katzav S, Weiss A . 1995 Mol. Cell. Biol. 15: 4337–4346
Wu J, Motto DG, Koretzky GA, Weiss A . 1996 Immunity 4: 593–602
Yablonski D, Kuhne MR, Kadlecek T, Weiss A . 1998 Science 281: 413–416
Ye ZS, Baltimore D . 1994 Proc. Natl. Acad. Sci. USA 91: 12629–12633
Zeng L, Sachdev P, Yan L, Chan JL, Trenkle T, McClelland M, Welsh J, Wang LH . 2000 Mol. Cell. Biol. 20: 9212–9224
Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE . 1998a Cell 92: 83–92
Zhang W, Trible RP, Samelson LE . 1998b Immunity 9: 239–246
Zhu J, McKeon F . 2000 Cell Mol. Life Sci. 57: 411–420
Acknowledgements
The author likes to thank Drs Eugenio Santos, Victor Tybulewicz and Martin Turner for communicating results prior to publication, and Drs Fátima Núñez and Mercedes Dosil for their comments on the manuscript. XR Bustelo is a CSIC member whose work is supported by the US National Cancer Institute (CA7373501), the British Association for International Cancer Research (00-061), the Programa General del Conocimiento of the Spanish Ministry of Science and Technology (PM99-0093), and the Programa FEDER of the Spanish Ministry of Education/European Union (1FD97-2116).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bustelo, X. Vav proteins, adaptors and cell signaling. Oncogene 20, 6372–6381 (2001). https://doi.org/10.1038/sj.onc.1204780
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204780
Keywords
This article is cited by
-
Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma
British Journal of Cancer (2024)
-
Differentiation of action mechanisms between natural and synthetic repellents through neuronal electroantennogram and proteomic in Aedes aegypti (Diptera: Culicidae)
Scientific Reports (2022)
-
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis
Leukemia (2021)
-
Regulation of sarcoma cell migration, invasion and invadopodia formation by AFAP1L1 through a phosphotyrosine-dependent pathway
Oncogene (2016)
-
VAV3 Oncogene Expression in Colorectal Cancer: Clinical Aspects and Functional Characterization
Scientific Reports (2015)